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CLINICAL EXPERIENiCE OF FLAVOXATE HYDROCHLORIDE
      （BLADDERON’ TABLET） IN UROLOGICAL FIELD
      WITH SPECIAL COMPARAT工VE STUDY ON THE CASES
             OF EXCELLENT AND POOR RESPONSE
     Shudo NAKANo and Kazuhisa lsE
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   Flavoxate．hydrochloride （B！adderon） was administered to 150 patients （inpatients and
outpatients） who had come to our department complaining of voiding disorder． The overall
clinical efficacy was assessed to be excellent in 4i patients （27．3％）， good in 42 patients
（28．Ofe16， ）， fair in 10 patients （6．7％） and poor in 57 patients （38．0％）； excellent and good
response being seen in 83 patients （55．3％）．
   Bladderon was more effective for cystitis， benign prostatic hypertrophy， nervous polla－
kisuria and nephroptosis： and the symptomatic improvement was remarkable for urinary
frequeney especially nocturia． This proves the clinical usefulness of Bladderon．
   The adequate dosage of Bladderon was 3－6 tablets daily although in cases of urinary
bladder carcinoma， a daily dose of 9一工2 tablets failed to lower urinary frequency。 There
tended to be more excellently responding cases among the younger patients， wh｛le there
tended to be more poorly responding cases among the aged patients．
   Drug－related side effects were obsefved in 9 patients， but a11 of them were mild gastro－
intestinal disorders． A comparative study of the cases with excellent and poor responses
revealed the prospectiv．en．ess of the clinic’≠?application of this drug．
   In follow．up study in the cases judged as poor must be皿ade in future to evaluate the
proper indications of this drug
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Table 3．疾患別効果
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Table 4．投与量別効果
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Tablc 5．投与期間別効果
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730 泌尿紀要29巻 6号 1983年
Table 6．抗生物質併用の有無による効果
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Fig．3．年齢層別著効例と無効例の比率
 （著効例十無効例を100とした場合）
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Fig．6． 抗生物質併用有無別著効例と無効例の比率



































































































爵    後     前    後
Fig．7．投与前後の排尿回数の推移
    （1）昼間の排尿回数
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Fig．8．投与前後の排尿回数の推移
    （2）夜間の排尿回数
著効例 40
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 前後  前後  前後
Fig．10．平均排尿回数の推移
     （1）著効例






















前      後       前      後
Fig．9．投与前後の排尿回数の推移
     ③ 1日の排尿回数
 前 後     前 後     前 後
Fig．11．平均排尿回数の推移
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